Literature DB >> 33742613

Posterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient.

Bora Korkmazer1, Murat Ozogul2, Emil Hikmat1, Huseyin Kilic3, Fatih Aygun3, Serdar Arslan1, Osman Kizilkilic1, Naci Kocer1.   

Abstract

Novel coronavirus disease 2019 is a viral infectious disease which commonly involve the lungs with primarily radiologic manifestations of atypical or organizing pneumonia. It can cause multisystemic involvement including central nervous system symptoms. One of these neurologic manifestations is posterior reversible encephalopathy syndrome (PRES). It is suggested that the increased levels of cytokines and inflammatory mediators in the course of the disease are responsible for cerebrovascular endothelial dysfunction and disruption of the blood-brain barrier. To the best of our knowledge, no pediatric PRES has been reported related to coronavirus disease 2019. Here, we present a pediatric PRES case associated with severe acute respiratory syndrome coronavirus 2 infection.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33742613     DOI: 10.1097/INF.0000000000003130

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  Spectrum of neuroimaging mimics in children with COVID-19 infection.

Authors:  Alex Mun-Ching Wong; Cheng Hong Toh
Journal:  Biomed J       Date:  2021-11-15       Impact factor: 7.892

2.  Unique Challenges Faced by a Child with Standard Risk Leukemia in Post-COVID Era: A Case Report.

Authors:  Swati Bhayana; Manas Kalra; Pallavi Sachdeva; Anil Sachdev; Anupam Sachdeva
Journal:  Indian J Crit Care Med       Date:  2022-06

3.  Posterior reversible encephalopathy syndrome and necrotizing enterocolitis in a pediatric patient with medulloblastoma and COVID-19 infection.

Authors:  Jacob Naman; Nicole Saglamer; Torun Yock; John Pugh; Gaetano Pastena; Lauren Weintraub
Journal:  Pediatr Blood Cancer       Date:  2022-07-16       Impact factor: 3.838

4.  Posterior reversible encephalopathy syndrome in a child with severe multisystem inflammatory syndrome due to COVID-19.

Authors:  Jesus Angel Dominguez-Rojas; Noe AtamariAnahui; Patrick Caqui-Vilca; Mariela TelloPezo; Pamela Muñoz-Huerta
Journal:  Rev Bras Ter Intensiva       Date:  2022 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.